Long-term 5-year outcome of the randomized IMPRESS in severe shock trial: percutaneous mechanical circulatory support vs. intra-aortic balloon pump in cardiogenic shock after acute myocardial infarction.
Mina KaramiErlend EriksenDagmar M OuweneelBimmer E P M ClaessenM Marije VisJan BaanMarcel BeijkErik J S PackerKrischan D SjauwAnnemarie EngstromAlexander VlaarWim K LagrandJose P S HenriquesPublished in: European heart journal. Acute cardiovascular care (2021)
In this explorative randomized trial of patients with severe CS after AMI, there was no difference in long-term 5-year mortality between pMCS and IABP-treated patients, supporting previously published short-term data and in accordance with other long-term CS trials.
Keyphrases
- acute myocardial infarction
- end stage renal disease
- newly diagnosed
- phase iii
- ejection fraction
- chronic kidney disease
- phase ii
- early onset
- open label
- clinical trial
- double blind
- prognostic factors
- percutaneous coronary intervention
- peritoneal dialysis
- study protocol
- electronic health record
- randomized controlled trial
- cardiovascular events
- pulmonary hypertension
- systematic review
- minimally invasive
- risk factors
- ultrasound guided
- placebo controlled
- drug induced
- data analysis
- atrial fibrillation
- deep learning